Home › Asset managers › Compare 2025-2026 › JPMorgan vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,248 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
JPMorgan 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 30,437 | 24,523 | 1,668 | 4,246 | 93.6% | 88.3% |
| Board proposals | 24,375 | 19,281 | 1,523 | 3,571 | 92.7% | 87.6% |
| E&S shareholder proposals | 144 | 7 | 0 | 137 | 100.0% | 43.7% |
| Other items | 5,918 | 5,235 | 145 | 538 | 97.3% | 92.5% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
3,571 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | JPMorgan | Brighthouse |
|---|---|---|---|---|---|---|
| BELDEN INC. | May 21, 2026 | Amendment and Restatement of the Belden 2021 Long Term Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
Split 6 FOR, 1 ABSTAIN |
| BELDEN INC. | May 21, 2026 | Ratification of the appointment of Ernst & Young as the Company's Independent Registered Public Accounting Firm for 2026. Audit-related |
Board | For | FOR 3 funds |
Split 6 FOR, 1 ABSTAIN |
| BENCHMARK ELECTRONICS, INC. | May 28, 2026 | To approve an amendment to the Benchmark Electronics, Inc. 2019 Omnibus Incentive Compensation Plan to increase the total number of authorized shares of the Company's common stock available for grant hereunder by 1,800,000 shares; and Compensation |
Board | For | AGAINST 4 funds |
Split 2 FOR, 1 AGAINST, 1 ABSTAIN |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | To approve, on an advisory (non-binding) basis, the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
Split 2 FOR, 2 ABSTAIN |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 2 ABSTAIN |
| BERKSHIRE HATHAWAY INC. | May 2, 2026 | Non-binding resolution to approve the compensation of the Company's Named Executive Officers, as described in the 2026 Proxy Statement. Say-on-Pay |
Board | For | FOR 29 funds |
Split 2 FOR, 7 AGAINST, 6 ABSTAIN |
| BEST BUY CO., INC. | June 12, 2026 | To approve in a non-binding advisory vote our named executive officer compensation Say-on-Pay |
Board | For | FOR 20 funds |
Split 4 FOR, 2 ABSTAIN |
| BEST BUY CO., INC. | June 12, 2026 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending January 30, 2027 Audit-related |
Board | For | FOR 16 funds |
Split 4 FOR, 2 ABSTAIN |
| BETA BIONICS, INC. | May 21, 2026 | To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 3 FOR, 1 ABSTAIN |
| BILLIONTOONE, INC. | June 10, 2026 | Ratify the appointment of PricewaterhouseCoopers LLP as BillionToOne, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 1 FOR, 1 ABSTAIN |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Approval of the Amended Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan. Compensation |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors. Audit-related |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| BIOCRYST PHARMACEUTICALS, INC. | June 11, 2026 | To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. Compensation |
Board | For | FOR 2 funds |
Split 3 AGAINST, 1 ABSTAIN |
| BIOCRYST PHARMACEUTICALS, INC. | June 11, 2026 | To hold a non-binding, advisory vote regarding executive compensation. Say-on-Pay |
Board | For | FOR 3 funds |
Split 3 AGAINST, 1 ABSTAIN |
| BIOCRYST PHARMACEUTICALS, INC. | June 11, 2026 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for 2026. Audit-related |
Board | For | FOR 2 funds |
Split 3 FOR, 1 ABSTAIN |
| BIOGEN INC. | June 9, 2026 | Say on Pay - To hold an advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 12 funds |
Split 5 FOR, 1 AGAINST, 6 ABSTAIN |
| BIOGEN INC. | June 9, 2026 | To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 10 funds |
Split 5 FOR, 1 AGAINST, 6 ABSTAIN |
| BIOHAVEN LTD | April 28, 2026 | A non-binding advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
Split 4 FOR, 1 ABSTAIN |
| BIOHAVEN LTD | April 28, 2026 | Election of Director for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. Heffernan Director Elections |
Board | For | FOR 3 funds |
Split 1 FOR, 1 ABSTAIN |
| BIOHAVEN LTD | April 28, 2026 | Ratification of appointment of Ernst & Young LLP as independent auditors for fiscal year 2026. Audit-related |
Board | For | FOR 3 funds |
Split 4 FOR, 1 ABSTAIN |
| BIOMARIN PHARMACEUTICAL INC. | June 2, 2026 | To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended. Compensation |
Board | For | FOR 3 funds |
Split 4 FOR, 1 ABSTAIN |
| BIOMARIN PHARMACEUTICAL INC. | June 2, 2026 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 4 funds |
Split 2 FOR, 2 AGAINST, 1 ABSTAIN |
| BIOMARIN PHARMACEUTICAL INC. | June 2, 2026 | To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 4 FOR, 1 ABSTAIN |
| BIOMERIEUX SA | May 28, 2026 | APPROVE COMPENSATION OF ALEXANDRE MERIEUX, CHAIRMAN OF THE BOARD Say-on-Pay |
Board | For | FOR 5 funds |
Split 3 FOR, 1 AGAINST |
| BIONTECH SE | May 15, 2026 | Approve Remuneration Report Say-on-Pay |
Board | For | AGAINST 2 funds |
Split 1 FOR, 1 AGAINST |
| BJ'S WHOLESALE CLUB HOLDINGS, INC. | June 18, 2026 | Approve, on an advisory (non-binding) basis, the compensation of the named executive officers of BJ's Wholesale Club Holdings, Inc. Say-on-Pay |
Board | For | FOR 15 funds |
Split 5 FOR, 3 ABSTAIN |
| BJ'S WHOLESALE CLUB HOLDINGS, INC. | June 18, 2026 | Ratify the appointment of PricewaterhouseCoopers LLP as BJ's Wholesale Club Holdings, Inc.'s independent registered public accounting firm for the fiscal year ending January 30, 2027. Audit-related |
Board | For | FOR 13 funds |
Split 5 FOR, 3 ABSTAIN |
| BLACK HILLS CORPORATION | April 29, 2026 | Advisory resolution to approve executive compensation. Say-on-Pay |
Board | For | FOR 5 funds |
Split 5 FOR, 1 ABSTAIN |
| BLACK HILLS CORPORATION | April 29, 2026 | Ratification of the appointment of Deloitte & Touche LLP to serve as Black Hills Corporation's independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 4 funds |
Split 5 FOR, 1 ABSTAIN |
| BLACKBAUD, INC. | June 10, 2026 | ADVISORY VOTE TO APPROVE THE 2025 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. Say-on-Pay |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| BLACKBAUD, INC. | June 10, 2026 | APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE BLACKBAUD, INC. 2016 EQUITY AND INCENTIVE COMPENSATION PLAN. Compensation |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| BLACKBAUD, INC. | June 10, 2026 | RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| BLACKLINE, INC. | May 7, 2026 | Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
Split 3 FOR, 1 AGAINST, 1 ABSTAIN |
| BLACKROCK, INC. | May 20, 2026 | Approval, in a non-binding advisory vote, of the compensation for named executive officers. Say-on-Pay |
Board | For | FOR 9 funds |
Split 5 FOR, 3 AGAINST, 1 ABSTAIN |
| BLACKROCK, INC. | May 20, 2026 | Ratification of the appointment of Deloitte LLP as BlackRock's independent registered public accounting firm for the fiscal year 2026. Audit-related |
Board | For | FOR 7 funds |
Split 8 FOR, 1 ABSTAIN |
| BLACKSTONE MORTGAGE TRUST, INC. | June 26, 2026 | Advisory Vote on Executive Compensation: To approve in a non-binding, advisory vote, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| BLACKSTONE MORTGAGE TRUST, INC. | June 26, 2026 | Ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 1 fund |
Split 2 FOR, 1 ABSTAIN |
| BLOCK, INC. | June 16, 2026 | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. Say-on-Pay |
Board | For | FOR 5 funds |
Split 7 FOR, 1 AGAINST, 2 ABSTAIN |
| BLOCK, INC. | June 16, 2026 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 8 FOR, 2 ABSTAIN |
| BLOOM ENERGY CORPORATION | May 21, 2026 | To approve an amendment to our Restated Certificate of Incorporation to remove outdated references to our Class B common stock. Capital Structure |
Board | For | FOR 5 funds |
Split 6 FOR, 3 ABSTAIN |
| BLOOM ENERGY CORPORATION | May 21, 2026 | To approve, on an advisory basis, the fiscal 2025 compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
Split 6 FOR, 3 ABSTAIN |
| BLOOM ENERGY CORPORATION | May 21, 2026 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal 2026. Audit-related |
Board | For | FOR 5 funds |
Split 6 FOR, 3 ABSTAIN |
| BLOOMIN' BRANDS, INC. | April 22, 2026 | Advisory Vote on Executive Compensation Say-on-Pay |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| BLOOMIN' BRANDS, INC. | April 22, 2026 | Ratification of Independent Registered Certified Public Accounting Firm Audit-related |
Board | For | FOR 1 fund |
Split 2 FOR, 1 ABSTAIN |
| BLUE OWL CAPITAL INC. | June 4, 2026 | The ratification of the appointment of KPMG LLP as our independent registered public accounting firm for our 2026 fiscal year. Audit-related |
Board | For | FOR 1 fund |
Split 1 FOR, 1 ABSTAIN |
| BOISE CASCADE COMPANY | April 30, 2026 | Advisory vote approving the Company's executive compensation. Say-on-Pay |
Board | For | FOR 6 funds |
Split 3 FOR, 2 ABSTAIN |
| BOISE CASCADE COMPANY | April 30, 2026 | To ratify the appointment of KPMG as the Company's external auditors for the year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 3 FOR, 2 ABSTAIN |
| BOK FINANCIAL CORPORATION | May 5, 2026 | Ratification of the selection of Ernst & Young LLP as BOK Financial Corporation's independent auditors for the fiscal year ending December 31, 2026. Audit-related |
Board | For | Split 1 FOR, 1 AGAINST |
FOR 2 funds |
| BOOKING HOLDINGS INC. | June 2, 2026 | Advisory vote to approve 2025 executive compensation. Say-on-Pay |
Board | For | FOR 29 funds |
Split 7 FOR, 1 AGAINST, 7 ABSTAIN |
| BOOKING HOLDINGS INC. | June 2, 2026 | Ratification of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 26 funds |
Split 7 FOR, 1 AGAINST, 7 ABSTAIN |
| BORGWARNER INC. | April 29, 2026 | Approve the Amended and Restated BorgWarner Inc. 2023 Stock Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
Split 5 FOR, 6 ABSTAIN |
| BORGWARNER INC. | April 29, 2026 | Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
Split 5 FOR, 6 ABSTAIN |
| BORGWARNER INC. | April 29, 2026 | Ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for 2026. Audit-related |
Board | For | FOR 4 funds |
Split 5 FOR, 6 ABSTAIN |
| BOSTON SCIENTIFIC CORPORATION | April 30, 2026 | To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance. Compensation |
Board | For | FOR 22 funds |
Split 8 FOR, 7 AGAINST |
| BOSTON SCIENTIFIC CORPORATION | April 30, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 26 funds |
Split 7 FOR, 1 AGAINST, 7 ABSTAIN |
| BOSTON SCIENTIFIC CORPORATION | April 30, 2026 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year. Audit-related |
Board | For | FOR 22 funds |
Split 7 FOR, 1 AGAINST, 7 ABSTAIN |
| BOX, INC. | June 25, 2026 | To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan to increase the number of shares reserved for issuance by 7,200,000 shares. Compensation |
Board | For | FOR 7 funds |
Split 1 FOR, 2 AGAINST, 2 ABSTAIN |
| BOX, INC. | June 25, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 10 funds |
Split 3 FOR, 2 ABSTAIN |
| BOX, INC. | June 25, 2026 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending January 31, 2027. Audit-related |
Board | For | FOR 7 funds |
Split 3 FOR, 2 ABSTAIN |
| BOYD GAMING CORPORATION | May 7, 2026 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 10 funds |
Split 4 FOR, 1 ABSTAIN |
| BOYD GAMING CORPORATION | May 7, 2026 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 8 funds |
Split 4 FOR, 1 ABSTAIN |
| BRAZE, INC. | June 30, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
Split 2 AGAINST, 1 ABSTAIN |
| BRAZE, INC. | June 30, 2026 | To ratify the selection by the audit committee of our board of directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2027. Audit-related |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| BREAD FINANCIAL HOLDINGS, INC. | May 19, 2026 | ADVISORY VOTE ON EXECUTIVE COMPENSATION Say-on-Pay |
Board | For | FOR 1 fund |
Split 3 FOR, 1 ABSTAIN |
| BREAD FINANCIAL HOLDINGS, INC. | May 19, 2026 | APPROVAL OF THE 2026 EMPLOYEE STOCK PURCHASE PLAN Compensation |
Board | For | FOR 1 fund |
Split 3 FOR, 1 AGAINST |
| BREAD FINANCIAL HOLDINGS, INC. | May 19, 2026 | RATIFICATION OF THE SELECTION OF DELOITTE & TOUCHE LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR 2026 Audit-related |
Board | For | AGAINST 1 fund |
Split 3 FOR, 1 ABSTAIN |
| BRENNTAG SE | May 20, 2026 | APPROVE REMUNERATION POLICY Say-on-Pay |
Board | For | AGAINST 2 funds |
Split 1 FOR, 2 AGAINST |
| BRENNTAG SE | May 20, 2026 | APPROVE REMUNERATION REPORT Say-on-Pay |
Board | For | FOR 4 funds |
Split 1 FOR, 2 AGAINST |
| BRIDGEBIO PHARMA, INC. | June 22, 2026 | To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares. Compensation |
Board | For | FOR 7 funds |
Split 4 FOR, 2 AGAINST, 3 ABSTAIN |
| BRIDGEBIO PHARMA, INC. | June 22, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 8 funds |
Split 6 FOR, 3 ABSTAIN |
| BRIDGEBIO PHARMA, INC. | June 22, 2026 | To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 7 funds |
Split 6 FOR, 3 ABSTAIN |
| BRIGHTHOUSE FINANCIAL, INC. | June 2, 2026 | Advisory vote to approve the compensation paid to Brighthouse Financial's Named Executive Officers Say-on-Pay |
Board | For | FOR 2 funds |
Split 3 FOR, 1 ABSTAIN |
| BRIGHTHOUSE FINANCIAL, INC. | June 2, 2026 | Ratification of the appointment of Deloitte & Touche LLP as Brighthouse Financial's independent registered public accounting firm for fiscal year 2026 Audit-related |
Board | For | FOR 1 fund |
Split 3 FOR, 1 ABSTAIN |
| BRIGHTSPRING HEALTH SERVICES, INC. | May 21, 2026 | Advisory vote on executive compensation Say-on-Pay |
Board | For | FOR 4 funds |
Split 5 FOR, 3 ABSTAIN |
| BRIGHTSPRING HEALTH SERVICES, INC. | May 21, 2026 | Ratification of the appointment of KPMG LLP as the independent accounting firm for the year ending December 31, 2026 Audit-related |
Board | For | FOR 3 funds |
Split 4 FOR, 3 ABSTAIN |
| BRISTOL-MYERS SQUIBB COMPANY | May 5, 2026 | Advisory Vote to Approve the Compensation of our Named Executive Officers Say-on-Pay |
Board | For | FOR 38 funds |
Split 7 FOR, 6 ABSTAIN |
| BRISTOL-MYERS SQUIBB COMPANY | May 5, 2026 | Ratification of the Appointment of an Independent Registered Public Accounting Firm Audit-related |
Board | For | FOR 34 funds |
Split 7 FOR, 6 ABSTAIN |
| BRISTOW GROUP INC. | June 3, 2026 | Advisory Vote to Approve Named Executive Officer Compensation. Say-on-Pay |
Board | For | FOR 1 fund |
Split 2 FOR, 1 ABSTAIN |
| BRIXMOR PROPERTY GROUP INC | April 22, 2026 | To approve, on a non-binding advisory basis, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
Split 4 FOR, 2 ABSTAIN |
| BRIXMOR PROPERTY GROUP INC | April 22, 2026 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 5 funds |
Split 4 FOR, 2 ABSTAIN |
| BROADCOM INC | April 20, 2026 | Advisory vote to approve the named executive officer compensation. Say-on-Pay |
Board | For | FOR 38 funds |
Split 5 FOR, 8 AGAINST, 6 ABSTAIN |
| BROADCOM INC | April 20, 2026 | Ratification of the appointment of Pricewaterhouse-Coopers LLP as the independent registered public accounting firm of Broadcom for the fiscal year ending November 1, 2026. Audit-related |
Board | For | FOR 34 funds |
Split 6 FOR, 6 ABSTAIN |
| BROADSTONE NET LEASE INC | April 30, 2026 | To approve, in a non-binding advisory vote, the compensation of the Company's named executive officers as described in the Company's 2026 proxy statement; Say-on-Pay |
Board | For | FOR 8 funds |
Split 4 FOR, 1 ABSTAIN |
| BROADSTONE NET LEASE INC | April 30, 2026 | To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026; Audit-related |
Board | For | FOR 7 funds |
Split 4 FOR, 1 ABSTAIN |
| BROWN & BROWN, INC. | May 6, 2026 | To approve an amendment to Brown & Brown, Inc.'s 2019 Stock Incentive Plan to increase the number of shares available for issuance under the plan and extend the term. Compensation |
Board | For | FOR 6 funds |
Split 6 FOR, 2 ABSTAIN |
| BROWN & BROWN, INC. | May 6, 2026 | To approve, on an advisory basis, the compensation of named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
Split 6 FOR, 2 ABSTAIN |
| BROWN & BROWN, INC. | May 6, 2026 | To ratify the appointment of Deloitte & Touche LLP as Brown & Brown, Inc.'s independent registered public accountants for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 6 funds |
Split 6 FOR, 2 ABSTAIN |
| BRUKER CORPORATION | May 21, 2026 | Approval on an advisory basis of the 2025 compensation of our named executive officers, as discussed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| BRUKER CORPORATION | May 21, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as our Independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| BRUNSWICK CORPORATION | May 6, 2026 | Advisory vote to approve the compensation of our Named Executive Officers. Say-on-Pay |
Board | For | FOR 5 funds |
Split 2 FOR, 2 ABSTAIN |
| BRUNSWICK CORPORATION | May 6, 2026 | The ratification of the Audit and Finance Committee's appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 2 ABSTAIN |
| BUILDERS FIRSTSOURCE, INC. | May 14, 2026 | An advisory vote on the compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
Split 6 FOR, 1 AGAINST, 1 ABSTAIN |
| BUILDERS FIRSTSOURCE, INC. | May 14, 2026 | The approval of the Builders FirstSource, Inc. Employee Stock Purchase Plan. Compensation |
Board | For | FOR 5 funds |
Split 7 FOR, 1 AGAINST |
| BUILDERS FIRSTSOURCE, INC. | May 14, 2026 | The ratification of PricewaterhouseCoopers LLP as our independent registered public accounting firm. Audit-related |
Board | For | FOR 5 funds |
Split 6 FOR, 1 AGAINST, 1 ABSTAIN |
| BUNGE GLOBAL SA | May 20, 2026 | Advisory Vote on the Swiss Compensation Report Say-on-Pay |
Board | For | FOR 8 funds |
Split 4 FOR, 3 ABSTAIN |
| BUNGE GLOBAL SA | May 20, 2026 | Advisory Vote to Approve Named Executive Officer Compensation Under U.S. Securities Law Requirements. Say-on-Pay |
Board | For | FOR 9 funds |
Split 4 FOR, 3 ABSTAIN |
| BUNGE GLOBAL SA | May 20, 2026 | Appointment of Independent Auditor for U.S. Securities Law Requirements and Reelection of Statutory Auditor for Swiss Law Requirements. Audit-related |
Board | For | FOR 5 funds |
Split 4 FOR, 3 ABSTAIN |
| BUNGE GLOBAL SA | May 20, 2026 | Approval of a Cash Dividend in the Aggregate Amount of U.S. $2.88 Per Outstanding Share Out of Bunge Global SA's Reserve from Capital Contributions in Four Equal Installments. Capital Structure |
Board | For | FOR 5 funds |
Split 4 FOR, 3 ABSTAIN |
| BUNGE GLOBAL SA | May 20, 2026 | Approval of the Maximum Aggregate Compensation of the Board for the Period between the 2026 Annual General Meeting and the 2027 Annual General Meeting Compensation |
Board | For | FOR 5 funds |
Split 1 FOR, 3 ABSTAIN |
← Previous Page 5 of 36 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.